Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study
(Q38670952)
scientific article published on 04 December 2015
scientific article published on 04 December 2015
Language:
Current Data About
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study
other details
description | scientific article published on 04 December 2015 |
External Links
(P356) |
10.1016/S0140-6736(15)00667-4
|
(P698) |
26673811
|